Company / Revenue per Share
Tandem Diabetes Care Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$15.31
FY2025
5-year range
$5.81 / $15.31
FY2021-FY2025
Trend
+6.8%
vs FY2024
Sector context
#96 of 153
Health Care
What the data says
At $15.31, Tandem Diabetes Care's revenue per share ranks #96 of 153 in the Health Care sector. Revenue per Share has increased for 6 consecutive years, from $1.87 in FY2019 to $15.31 in FY2025.
Based on SEC 10-K filings.
15.31 in FY2025 with a 5-year CAGR of +37.7%.
Improved from $11.59 to $15.31 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +25.1%
- 5-Year CAGR
- +37.7%
- 10-Year CAGR
- -
Sector benchmark
#96 of 153 in Health CareTop 63% of 153This company $15.31 Sector average $124.28
▼
-87.7% below sector average
Key checks
Key Insights
- Tandem Diabetes Care's revenue per share has grown for 6 consecutive years.
- In FY2025, revenue per share increased 6.8% year-over-year.
- Ranks #96 out of 153 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.31 | +6.8% |
| FY2024 | $14.34 | +23.7% |
| FY2023 | $11.59 | +48.3% |
| FY2022 | $7.81 | +34.5% |
| FY2021 | $5.81 | +87.8% |
| FY2020 | $3.10 | +65.6% |
| FY2019 | $1.87 | -77.5% |
| FY2018 | $8.33 | -64.5% |
| FY2017 | $23.42 | +741.2% |
| FY2016 | $2.78 | -9.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026